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Background: Sarcopenia, the loss of muscle mass and strength, is associated with adverse health outcomes. Calf circumference
(CC) has been proposed as a surrogate measure of muscle mass in the elderly; however, ethnic/sex specific cut-off values remain
to be established.
Objective: A study was undertaken to investigate the relationship between CC and appendicular skeletal muscle mass (ASM),
and the ASM index (ASMI), as well as to determine whether CC could be used to diagnose sarcopenia.
Methods: This was a cross-sectional study of 247 older black women living from Tlokwe, South Africa. ASM was measured using
dual-energy X-ray absorptiometry, and the ASMI was calculated. Receiver operator characteristics curves and maximum Youden
index were applied to identify a CC cut-off point for sarcopenia according to low gait speed (< 0.8 m/s), low hand-grip strength
(< 16 kg) and low ASMI using a South African cut-off point for sarcopenia (ASMI < 4.94 kg/m2).
Results: A strong positive correlation between CC and ASMI (r = 0.84, p < 0.001) was observed. The CC to predict low hand-grip
strength was 34.3 cm and 37.8 cm for low gait speed. A CC of 29.9 cm was indicative of sarcopenia. The area under the curve for
all outcomes was > 0.60.
Conclusion: A CC of 30 cm is proposed as a simple and inexpensive way to predict, screen or diagnose sarcopenia in black
women in low-resource health settings. An accessible, inexpensive screening or diagnostic tool could facilitate timely
interventions and prevention.
Keywords: gait speed, geriatric, hand-grip strength, muscle strength, sarcopenia
Introduction
Sarcopenia, a progressive and generalised loss of muscle mass
and strength that occurs throughout the ageing process, is con-
sidered a public health concern in low- and middle-income
countries, particularly among geriatric populations.1,2 Sarcope-
nia is associated with many adverse outcomes that may
impact negatively on the elderly, such as increased incidence
of falls, physical dysfunction, reduction in quality of life, and
increased morbidity3 and mortality.4
The prevalence of sarcopenia is reported to be between 8% and
50% in people over the age of 50 years, depending on ethnicity,
age, setting and diagnostic methodology.5,6 In 2010, the Euro-
pean Working Group on Sarcopenia in Older People (EWGSOP)
released guidelines for the diagnosis of sarcopenia and
defined it as the presence of both low muscle mass and low
muscle function (strength or performance).4,7 A South African
cut-off point for sarcopenia based on appendicular skeletal
muscle mass (ASM) index (ASMI) was recently proposed.8
According to this cut-off point, 9.1% of the study participants
were sarcopenic.8
Sarcopenia is recognised as a multi-faceted syndrome caused by
various factors. Muscle functionality and physiology can affect
muscle performance due to age-related changes in body com-
position.9 The ageing process results in a decrease of muscle
mass and muscle contractibility. Therefore, a low lean mass to
total body mass can reduce functional performance and
muscle strength.10,11 The decreased contraction of muscle
fibres and functionality of older adults could be explained by
age-related fat infiltration in muscle tissues.12 Functional per-
formance can be measured by using grip strength, timed chair
stand performance, standing balance, timed get-up-and-go
test, stair climb power test and normal walking speed, among
others.4,9 Reduced functional performance is associated with a
reduction in physical activity levels, which in turn leads to
reduced anabolic stimulus of skeletal muscle, thereby contribut-
ing to muscle wasting over time. Other factors that may contrib-
ute to a decrease in functional performance and have an impact
on the relationship between disability and sarcopenia are
inflammation, nutrition, protein turnover and hormonal
changes.13
Diagnosis of sarcopenia requires measurement of muscle
strength as well as body composition. Low skeletal muscle
mass can be measured by techniques such as dual-energy X-
ray absorptiometry (DXA), computed tomography (CT), mag-
netic resonance imaging and bio-impedance analysis.7 Most of
these methods are, however, poorly accessible, expensive and
some procedures expose subjects to radiation.14 Various cut-
off points for ASM and ASMI together with measures of
muscle strength and physical performance have been proposed
to identify sarcopenia.15,16 Baumgartner et al.15 in the New
Mexico Aging Process Study summed up the measurements of
the four extremities in the body using a DXA scan. The sum of
these four extremities called ASM were used to define cut-off
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values for sarcopenia.15 Sex-specific cut-off points for sarcopenia
were defined as an ASMI two standard deviations below the
mean ASMI of the male and female reference groups.15
Calf circumference (CC) has been proposed as a simple and
affordable measure to estimate muscle mass in the elderly.17
In a Japanese study of 526 participants, CC was positively corre-
lated with ASM and ASMI, and was also associated with the diag-
nosis of sarcopenia.18 Correlation between ASM and CC in the
New Mexico Aging Process Study was twice as high as the cor-
relation between mid-arm circumference and ASM.15 People
with a high CC rarely present with a poor nutritional status.19 Evi-
dence also suggests that CC atrophy occurs with physical impair-
ment, functional incapacity or mobility and, therefore, future
research is needed to determine whether impairment leads to
muscle atrophy or whether physical impairment is followed by
atrophy of muscle.20
South Africa is a middle-income country and DXA and CT tech-
nology are not generally available or accessible as measurement
tools to diagnose sarcopenia. The most common method avail-
able for the identification of sarcopenia in low- and middle-
income countries used by healthcare professionals is anthropo-
metric measurement tools. The purpose of this study was to
investigate the relationship between CC and ASMI, and to deter-
mine whether CC could be used to diagnose sarcopenia in a
group of older black South African women from Tlokwe City.
Materials and methods
Design and setting
Data collected between 2012 and 2013 from the South African
arm of the Prospective Urban and Rural Epidemiological
(PURE) study were used. The PURE study is aimed at assessing
the effects of lifestyle on the development of non-communic-
able diseases. Sample size was estimated using a pre-deter-
mined sensitivity of 70% (0.70), 95% confidence and 80%
power to detect a difference of 10% (0.10) between participants
with and without the condition, in this case sarcopenia.21
According to these calculations, 153 participants were needed
to determine the diagnostic ability of CC. Our final sample
included more, as we had data for 247 individuals. Urban
black South African women residing in Tlokwe City of the
North West province, older than 45 years with good physical
and psychological health and living independently and who
were part of the PURE North West study were eligible. Due to
participants rarely disclosing their human immunodeficiency
virus (HIV) status, healthy persons with HIV could participate,
provided that they were not acutely ill and lived independently.
Exclusion criteria included being of the male sex, participants
with disabilities, taking anabolic steroids or protein sup-
plements, pregnant or lactating women and those with
current serious diseases, including acute HIV infection. Approval
for the study was given by the Health Research Ethics Commit-
tee of North-West University (NWU) in compliance with ethics
rules for human experimentation in the Declaration of Helsinki.
All volunteers provided written informed consent to participate
in the study.
Measures
Anthropometry and body composition
Measurements were carried out by trained anthropometrists
using standard calibrated instruments and methods prescribed
by the International Society for the Advancement of Kinanthro-
pometry (ISAK).22 Weight was measured to the nearest 0.1 kg
using an electronic scale (Seca, Birmingham, UK) and height
was recorded to the nearest 0.1 m using a stadiometer (Seca, Bir-
mingham, UK) with participants lightly clothed and shoes
removed. Body mass index (BMI) was calculated as weight (kg)
divided by height in metres squared. CC was measured using
a flexible steel tape (Lufkin, Cooper tools, Apex, NC, USA) with
participants in a standing position. The tape was placed
around the calf at the level of maximal girth without compres-
sing the subcutaneous tissues. Measurement was taken from
the lateral side of the body measuring to the nearest 0.1 cm.
A registered radiographer measured body composition (fat-free
mass for the whole body, arms and legs) using DXA with default
settings (Hologic Discovery W, APEX system software version
2.3.1). ASM was defined as the sum of fat-free muscle mass of
the arms and legs, excluding bone mass, while ASMI was calcu-
lated as ASM divided by the square of the height (kg/m2). The
South African cut-off point for sarcopenia of ASM < 4.94 kg/m2
was used to define sarcopenia.23
Physical performance and strength tests
Grip strength was assessed using a hand grip dynamometer
(Jamar, Bollingbrook, IL, USA) and recorded to the nearest
0.1 kg. Participants were asked to hold the dynamometer in
the dominant hand with elbow flexed at a 90° angle and
forearm parallel to the floor. The dynamometer was maximally
squeezed for 5 seconds. The maximum strength of two repeated
measurements was used in this study.24 Low hand-grip strength
was regarded as < 16 kg for women.24 Gait speed (m/s) was used
to assess physical performance. Participants were asked to com-
plete a 6 m walk test. The time taken to complete the test was
recorded with a stop watch and the speed (m/s) calculated.25
A low gait speed was defined as < 0.8 m/s.25
Data analysis
Statistical analysis was performed using SPSS version 22 for
Windows (SPSS, Chicago, IL, USA). Normality of variables was
tested using Kolmogorov–Smirnov and Shapiro–Wilk tests. Nor-
mally distributed data were reported as means (SD), and non-
normally distributed data as median and interquartile ranges
(IQR). Categorical variables were described with frequencies
and percentages. Because most variables deviated from the
normal distribution, the Mann–Whitney test was used to
compare the median values of the characteristics of sarcopenic
and non-sarcopenic participants. Pearson’s correlation coeffi-
cient was used to determine the association between CC and
DXA-measured ASM and ASMI. Receiver operating character-
istics (ROC) curves were used to determine the optimal
Youden index cut-off value of CC in predicting sarcopenia. A
p-value of less than 0.05 was regarded as statistically significant.
Results
Table 1 presents the characteristics of the women. The weight,
BMI, ASM, ASMI, hand-grip strength, gait speed and CC, respect-
ively, of the sarcopenic women were significantly lower than the
same variables of the non-sarcopenic women. A positive corre-
lation was observed between CC and ASMI (r = 0.84; p < 0.001).
Table 2 represents the ROC analysis for sensitivity and specificity
of CC to predict low gait speed, low hand-grip strength and sar-
copenia. To predict low gait speed (< 0.8 m), a CC cut-off point of
37.8 cm was established with a sensitivity of 93.8% and speci-
ficity of 41.2% (Figure 1a). For low hand-grip strength (<
16 kg), a CC cut-off point of 34.3 cm was calculated with a sen-
sitivity and specificity of 66.7% and 64.4%, respectively (Figure
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1b, Table 2). Using the South African sarcopenia cut-off point, i.e.
ASMI of 4.94 kg/m2, to predict sarcopenia, a CC value of 29.9 cm
was calculated to have a 100% sensitivity and 93.3% specificity
(Figure 1c). The lower limit of the 95% confidence intervals (CI)
for the area under the curve (AUC) of gait speed (0.57) was <
0.6, which is considered as the cut-off point for the adequate
diagnostic performance of a variable. Hand-grip strength and
the South African sarcopenia cut-off points both demonstrated
good diagnostic performance (lower limits of the 95% CI of
0.61 and 0.96, respectively). The cut-off point values, 37.8 cm
and 34.3 cm, for CC to diagnose low gait speed (< 0.8 m) and
low hand-grip strength (< 16 kg), respectively are greater than
the CC cut-off point (29.9 cm) to diagnose sarcopenia when
using the South African cut-off point. Therefore we propose a
CC cut-off point rounded to 30 cm, which is also easier to
remember and apply in practice. The prevalence of sarcopenia
in the participants using the South African cut-off point (ASMI
< 4.94 kg/m2) was 8.91% (n = 22), whereas when using the
newly derived CC cut-off point of 30 cm, 10% more women,
i.e. 19.0% (n = 47 women), were sarcopenic.
Discussion
This is the first study to investigate a possible surrogate marker
for muscle mass in black South African women of Tswana ances-
try. We investigated the relationship between CC and ASMI, and
evaluated whether CC is a suitable measurement for lean mass
to diagnose sarcopenia in black South African women. Non-sar-
copenic patients presented with a higher CC than participants
diagnosed with sarcopenia. The average CC reported in this
study was similar to that reported on French (35 ± 3.1 cm) and
Korean (32.4 ± 2.8 cm) elderly women.20,26 A strong positive cor-
relation (r = 0.84; p < 0.001) was observed between CC and ASMI
in this group of black South African women.







(n = 225) p-value#
Age (years) 56 (50, 65) 58 (52.5, 62.5) 57 (50, 66) 0.92
Weight (kg) 69.9 (55.3, 84.3) 41.6 (39.4, 45.1) 71.8 (58.1, 84.8) < 0.0001
Height (cm) 156 (152, 160) 156 (151, 162) 156 (152, 160) 0.97
Body mass index (kg/m2) 28.3 (22.8, 34.2) 17.7 (16.1, 18.8) 29.2 (24.2, 34.6) < 0.0001
Calf circumference (cm) 35.7 (31.5, 40.2) 27.5 (25.8, 28.3) 36.4 (32.4, 40.5) < 0.0001
ASM (kg) 16.2 (13.6, 18.9) 11.4 (9.96, 12.2) 16.6 (14.2, 19.2) < 0.0001
ASMI (kg/m2) 6.61 (5.75, 7.72) 4.68 (4.40, 4.84) 6.74 (6.04, 7.81) < 0.0001
Hand-grip strength (kg) 20.0 (16.0, 25.0) 16.0 (10.5, 20.5) 21.0 (16.0, 26.0) 0.003
Gait speed (m/s) 1.40 (1.18, 1.58) 1.39 (0.96, 1.58) 1.40 (1.18, 1.59) 0.04
Notes: Values are presented as medians (interquartile range, IQR); ASM = appendicular skeletal muscle; ASMI = appendicular skeletal muscle index.
*The South African cut-off point for sarcopenia of ASM < 4.94 kg/m2 was used to define sarcopenia.
#Difference between groups tested using the Mann–Whitney test.
Table 2: Sensitivity and specificity of CC to predict low gait speed, weak hand-grip strength and sarcopenia (ASMI < 4.94 kg/m2)
Variables
Number of participants identified by each
method (%) AUC (95% CI) Sensitivity Specificity
CC (cm) cut-off
point
Gait speed < 0.8 m/s 16 (6.5%) 0.70 (0.57, 0.83) 93.8% 41.2% 37.8
Hand-grip strength <
16 kg
51 (20.6%) 0.69 (0.61, 0.78) 66.7% 64.4% 34.3
SA sarcopenia cut-off
point
22 (8.9%) 0.94 (0.96, 1.00) 100% 93.3% 29.9
Notes: AUC = area under the curve; ASMI = appendicular skeletal muscle index; CC = calf circumference; CI = confidence interval.
Figure 1: ROC curve of CC to predict the presence of (A) low gait speed (< 0.8 m/s), (B) low hand-grip strength (< 16 kg), and (C) the presence of sarco-
penia according to a South African cut-off point.
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Previous studies in elderly French women, as well as in Japanese
and Korean women, also reported that DXA-measured ASM cor-
related positively with CC (r = 0.63, r = 0.69, and r = 0.55, respect-
ively).18,20,26 The predictive power of CC to assess lean body
mass could be influenced by leg oedema.18 The relationship
between CC and ASM in men has proven a higher correlation
than in women. The reason could be that women distribute
more fat mass on their lower extremities than men and, there-
fore, CC is a more sensitive marker for muscle mass in men
and lean women than in obese women.27 However, results of
a study conducted in both men and women failed to demon-
strate a positive relationship between CC and lower extremity
fat.28 Taking the above-mentioned into consideration, we con-
cluded that CC is a suitable surrogate measurement of muscle
mass in adults, except in obese individuals.
In our study, aCC cut-off point of 29.9 cmwasdetermined through
ROC curve analysis, and rounded to 30 cm to indicate sarcopenia
when using the South African cut-off point. To diagnose low gait
speed (< 0.8 m/s) and low grip strength (< 16 kg) respectively, a
greater CC was identified to diagnose sarcopenia than when
using the South African cut-off point. Authors of two studies18,26
reported cut-off points for Japanese and Korean women, respect-
ively, at 33 cm (sensitivity 76%, specificity 73%) for type I sarcope-
nia and a threshold of 34 cm (sensitivity 66%, specificity 74%) for
type II sarcopenia,18 and 33cm (sensitivity 83%, specificity 50%),26
respectively. In our ROC analysis, we observed similar cut-off
points of 37.8 cm to predict low gait speed with a high sensitivity
(93.8%)butwith lowspecificity (41.2%), and34.3 cmtopredict low
grip strength (sensitivity 66.7%, specificity 64.4%). However, in the
ROC analysis of the CC to predict sarcopenia according to South
African sarcopenia cut-off point, we found that 29.9 cm was the
value with a high sensitivity (100%) and specificity (93.3%). The
rounded CC cut-off point of 30 cm to predict sarcopenia is lower
when compared with the cut-off points for CC to predict both
low gait speed and low grip strength, as well as lower than
those determined in other published studies.18 Despite the
lower CC cut-off point, this CC cut-off point determined in our
study still overestimates the prevalence of sarcopenia. When the
CC cut-off point (30 cm) is used, women who are sarcopenic as
well as pre-sarcopenic according to the South African cut-off
values are included. The CC can, therefore, be used as primary pre-
vention screening tool for sarcopenia,which is sensitive to identify
pre-sarcopenia as well.
Participants with a low CC also demonstrated decreased physical
strength in terms of low hand-grip strength and low gait speed.
Hand-grip strength is in itself associated with all-cause mor-
tality.29 Because of this relationship between CC and physical
strength, other health outcomes are also closely associated
with CC. Sarcopenic individuals have a greater fall risk in com-
parison with their healthy counterparts, which also increases
their risk for disability or fractures.30 Cross-sectional studies
reported a two to five times greater likelihood of disability or
functional impairment in older adults with severe sarcopenia,
and sarcopenic obesity was associated with 2.6 times greater
risk of developing disability.15 Women have a higher risk of dis-
ability than men, the reason for which could be that women
present with less muscle mass than men at all ages.31
Sarcopenia is a multi-factorial syndrome that involves hormonal,
physical activity and immunological changes as well as central
and peripheral nervous system alterations.32 With age, atrophy of
muscle fibres causes a decline in muscle mass and strength.33
Lower grip strength is present in the elderly where function of
ciliary neutrophic factor, a protein that stimulates motor unit for-
mation, is diminished.34 Muscle detrition is a result of decreased
protein synthesis and decreased satellite cell activation that is
caused through a decrease in insulin-like growth factor-1 (IGF-1
andmechano growth factor.35 Another key role triggering sarcope-
nia can be mitochondrial DNA mutation resulting from mitochon-
drial reactive oxygen species, which leads to cell death and
breakdown.36 Hormonal and immunological changes caused by
increased catabolic activity (increased levels of interleukin (IL)-1,
IL-6, myostatin and tumour necrosis factor-alpha) and the resist-
ance or absence of anabolic factors (decreased levels of IGF-1,
growthhormone and testosterone) also contribute to sarcopenia.37
Aerobic exercises can prevent functional decline of the lower extre-
mities38 and resistance training can increase the rate of mixed
muscle protein synthesis in elderly participants.39 Fiatarone et al.40
conducted a randomised placebo-controlled trial wherein subjects
were placed on progressive exercise training, multi-nutrient sup-
plements and both interventions, and found a 3% to 11% increase
in muscle cross-sectional area.40 To maintain muscle strength and
endurance Haskell et al. suggested that resistance training should
be performed on two or more non-consecutive days each week
using the major muscle groups.41 The recommendations for main-
taining healthy muscles with ageing report that optimal protein
intakeof 1 to 1.2 g/kg/day resulted in an increase inmuscle function
and muscle mass.42 Similarly, Paddon-Jones and Rasmussen43
found that high-quality protein meals of 25–30 g/meal increased
protein synthesis and maintained skeletal muscle mass. Essential
amino acid supplementation can also prevent muscle loss.44
Paddon-Jones and Rasmussen also demonstrated a higher muscle
protein synthesis with essential amino acid supplementation.42
Vitamin D supplementation increases muscle strength and
decreases the risk of falls.45,46 A variety of pharmaceutical products
such as testosterone, anabolic steroids or selective androgen recep-
tormodulators, growth hormone, IGF-1, ghrelin,myostatin and acti-
vating II receptor inhibitors, espindolol, angiotensin converting
enzyme inhibitor (perindopril) and fast skeletal troponin activators
(Terasemtiv) are studied for the management of sarcopenia.35
In conclusion, CC is a useful surrogate indicator of ASM, with
good sensitivity but moderate specificity, to diagnose physical
performance or muscle strength in older black South African
women. Future studies should include at least more than one
physical performance test to diagnose sarcopenia, because sar-
copenia is not only a loss of muscle mass, but also of muscle
strength. Furthermore, similar studies should be conducted in
male participants to establish gender-specific thresholds of sur-
rogate markers to predict sarcopenia. A CC < 30 cm is a good
indicator of muscle mass and correlated significantly with
ASMI and may, therefore, be used as measurement to diagnose
sarcopenia in public health settings for black South African
women where resources are limited. Establishing that a
cheaper alternative than DXA measurements can be used to
diagnose sarcopenia is very valuable for low- and middle-
income countries as a screening tool.
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